Skip to main content
. 2023 Feb 17;164(1):53–64. doi: 10.1016/j.chest.2023.02.015

Table 3.

Construct Validity of Select QOL-B and NTM Symptoms Domains in Patients With MAC-PD

Measure and HRQoL Domain AFB Smear Results
FEV1 % Predicted
FVC % Predicted
Positive (n = 86) Negative (n = 117) P Value < 70 (n = 46) ≥70 (n = 112) P Value < 70 (n = 20) ≥ 70 (n =138) P Value
QOL-B
 Respiratory symptoms 65.1 ± 17.0 64.0 ± 17.0 .66 60.7 ± 17.3 67.1 ± 16.4 .03 56.2 ± 17.0 66.6 ± 16.5 .009
 Physical functioning 55.6 ± 32.1 61.6 ± 33.1 .20 51.8 ± 32.1 65.4 ± 30.9 .01 44.8 ± 31.5 63.9 ± 31.1 .01
 Vitality 59.4 ± 14.4 58.6 ± 12.4 .70 60.9 ± 13.8 57.7 ± 13.1 .18 61.1 ± 11.7 58.3 ± 13.5 .38
 Health perception 46.8 ± 19.1 47.0 ± 16.6 .96 48.9 ± 19.1 45.6 ± 17.9 .31 57.1 ± 15.8 45.1 ± 18.2 .006
NTM symptoms 79.7 ± 14.5 77.4 ± 17.5 .33 79.2 ± 15.9 78.2 ± 17.1 .73 76.8 ± 18.0 78.7 ± 16.6 .64

Dara are presented as mean ± SD. Boldface values indicate statistical significance at P < .05. AFB = acid-fast bacillus; HRQOL = health-related quality of life; MAC-PD = Mycobacterium avium complex pulmonary disease; NTM = nontuberculous mycobacteria; QOL-B = Quality of Life-Bronchiectasis.